Canopy Growth

(NYSE: CGC)
Healthcare  |  Drug Manufacturers—Specialty & Generic
16.44 -0.93 -5.35%
Stock Price | June 1, 2020, 4 p.m.
11 Followers
Bid: 0.0
Ask: 0.0
Prev. Close: 17.37
52 Week Low: 9.0
52 Week High: 44.17
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Pre-Market Edition 06/02/20

8 Comments
7 hours ago

Premium Cannabis Stocks Review - AM Edition 06/01/20

10 Comments
16 hours ago

Premium Cannabis Stocks Review - Weekend Edition 06/01/20

11 Comments
2 days ago

Premium Cannabis Sub-Sector Review - 05/29/20

6 Comments
2 days ago

Premium Weekly Review 05/29/20

1 Comments
3 days ago

Premium Cannabis Stocks Review - Pre-Market Edition 05/29/20

4 Comments
4 days ago

Premium Cannabis Stocks Review - AM Edition 05/28/20

2 Comments
4 days ago

Premium Toking Tuesday Chat - 05/26/20

2 Comments
6 days ago

Premium Earnings Previews for the Week Ending 05/29/20

2 Comments
1 week ago

Premium Cannabis Stocks Review - Weekend Edition 05/26/20

39 Comments
1 week ago